Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
NCT00185913 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2010-04-22
Summary
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Quynh-Thu Le · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-09-30
- Primary Completion
- 2003-10-31
- Completion
- 2008-05-31
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Liquid Biopsy for Early Non-small Lung Cancer Detection
NCT05462795 ·Status: COMPLETED
-
Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment
NCT03244904 ·Status: UNKNOWN
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN
-
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 ·Status: COMPLETED
-
Non-Invasive Biomarkers For Early Detection Of Lung Cancers
NCT01580332 ·Status: COMPLETED
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer
NCT01692951 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Collection of Blood Samples in Patients With Non-small Cell Lung Cancer
NCT03492801 ·Status: TERMINATED
-
EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer
NCT02154399 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102 ·Status: RECRUITING
-
Cancer of the Lung And SeneScencE - Prospective Cohort 1
NCT06923618 ·Status: RECRUITING ·Phase: NA
-
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355 ·Status: UNKNOWN
-
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
NCT06816121 ·Status: RECRUITING
-
Usefulness of Blood Biomarkers for Overall Survival in NSCLC
NCT01936571 ·Status: COMPLETED
-
Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
NCT01052818 ·Status: UNKNOWN
-
A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
NCT06503042 ·Status: NOT_YET_RECRUITING
-
Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle Aspirates
NCT01630122 ·Status: COMPLETED
-
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
NCT03791034 ·Status: RECRUITING
-
The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer
NCT01852838 ·Status: UNKNOWN
-
Study of Tumor Samples From Patients With Lung Cancer
NCT00900328 ·Status: COMPLETED
-
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer
NCT04951154 ·Status: COMPLETED
-
Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung Cancer
NCT04918836 ·Status: UNKNOWN